Featured Infographic
Most Medicare Part D Plans Incentivize Use of
Generics, Study Finds
For medications with both brand-name and generic versions,
an overwhelming majority of Medicare Part D plans encouraged the use of
generics over their brand-name equivalents in 2019, according to a study
published in Health Affairs. By analyzing Part D formulary coverage and
tier placement of matched brand-name drugs and generics, the researchers
found that 84% of Part D plan-product combinations covered the generic only
in 2019, while 15% covered both brand-name and generic versions. In 2019,
of the 1,361 drug products analyzed, there were 98% of products for which
generics were placed on a lower cost-sharing tier than their brand-name
counterparts in at least one plan in 2019.
NOTE: The study was funded by a grant from Arnold Ventures.
SOURCE:
"Medicare Part D Plans Rarely Cover Brand-Name Drugs When Generics Are
Available," Health Affairs 39, NO. 8 (2020): 1326–1333. Visit https://bit.ly/3k37XC5.
Subscribers may read the RADAR on Drug Benefits article in
which this infographic appeared online. Learn more about
subscribing to AIS Health's publications.
|
No comments:
Post a Comment